Aclaris Therapeutics (ACRS) Gross Profit (2016 - 2026)
Aclaris Therapeutics (ACRS) posted quarterly Gross Profit of $1.6 million for Q1 2026, up 68.7% year-over-year from $949000.0 in Q1 2025, and up 109.83% quarter-over-quarter from $763000.0 in Q4 2025.
Aclaris Therapeutics (ACRS) Gross Profit (2016 - 2026) Analysis & Trends
Aclaris Therapeutics' Gross Profit history runs 11 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Gross Profit rose 68.7% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $6.4 million (down 58.22% YoY), while the FY2025 annual figure was $5.7 million, down 63.99% from the prior year.
- Gross Profit for Q1 2026 stood at $1.6 million, up from $763000.0 in the prior quarter.
- The five-year high for Gross Profit was $18.1 million in Q3 2022, with the low at $298000.0 in Q1 2022.
- The 5-year median for Gross Profit is $1.7 million (2023), against an average of $4.5 million.
- The sharpest annual moves came in 2022 and 2025: Gross Profit jumped 3131.25% in 2022, then plunged 91.03% in 2025.
- Aclaris Therapeutics' Gross Profit stood at $6.9 million in 2022, then surged by 144.98% to $16.8 million in 2023, then slumped by 49.5% to $8.5 million in 2024, then slumped by 91.03% to $763000.0 in 2025, then surged by 109.83% to $1.6 million in 2026.
- Business Quant data shows ACRS's Gross Profit at $1.6 million in Q1 2026, $763000.0 in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Aclaris Therapeutics | 808.18 Mn | 716.63 Mn | 1.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.41 Mn |
| Jun 30, 2026 | 1.41 Mn |
| Mar 31, 2026 | 1.60 Mn |
| Mar 31, 2026 | 1.60 Mn |
| Dec 31, 2025 | 763,000.00 |
| Dec 31, 2025 | 763,000.00 |
| Sep 30, 2025 | 2.76 Mn |
| Sep 30, 2025 | 2.76 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 949,000.00 |
| Mar 31, 2025 | 949,000.00 |
| Dec 31, 2024 | 8.51 Mn |
| Dec 31, 2024 | 8.51 Mn |
| Sep 30, 2024 | 3.69 Mn |
| Sep 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.59 Mn |